AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Talus Replacement Registry

Recruitingn/aAges 18 Years - anyAllKyle Schweser MD
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Avascular necrosis of the talus is a difficult problem to manage, especially in the young and healthy. The only option, historically, has been a talectomy and hindfoot fusion. While this is a viable option, it is not without its morbidity. Arthritis of surrounding joints is common, occurring anywhere from 1-10 years after the procedure. This is especially true in younger patients, where loss of motion can be life altering both physically and mentally. The search for alternatives has been limited. Recently, 3D printing has become more ubiquitous and affordable and newer medical alternatives have arisen thanks to this technology. The 3D custom talus is relatively new in the orthopaedic community, but has been used at several centers with good success. It has been shown to re-establish the normal alignment of the foot, preserve motion (with some achieving almost physiologic motion), and all

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Subjects age 18 years or above at time of screening 2. Condition satisfies requirement for total talus replacement 3. Able to consent and participate in the study 4. No previous history of septic arthritis involving the hindfoot/midfoot 5. Previous ability to ambulate Exclusion Criteria: 1. Active infection, sepsis, osteomyelitis or history of septic arthritis involving the hindfoot/midfoot 2. Unable to consent or participate in the study secondary to mental status 3. Condition does not qualify for a total talus replacement 4. Patients who are pregnant or imprisoned 5. Planned relocation or unable to return for required follow-up visits
๐Ÿ’Š

What it tests

  • 3D talar augmentation
๐Ÿ“

Where

1 site
University of Missouri
Columbia, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy